Differentiated Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Differentiated Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer [Phase 3]
Phase 3 study evaluating dabrafenib plus trametinib in previously treated metastatic, radioactive iodine-refractory BRAF V600E–positive diff…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: Desiccated Thyroid Extract Combined With Levothyroxine for TSH Suppression Therapy in DTC [Phase 3]
Phase 3 trial evaluating desiccated thyroid extract combined with levothyroxine for TSH suppression in intermediate-to-high risk differentia…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Robotic Surgery Via Bilateral Axillo-breast Approach for Relatively Low-risk Papillary Thyroid Carcinoma With Lateral Cervical Lymph Node Metastasis: a Safe and Effective Cosmetic Procedure in the Context of Prevalent Thyroid Ultrasound Screening
This completed trial evaluates a robotic bilateral axillo-breast approach for relatively low-risk papillary thyroid carcinoma with lateral c…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Targeted Therapy to Increase RAI Uptake in Metastatic DTC
A clinical trial update announcing recruitment for a targeted therapy intended to increase radioiodine uptake in metastatic differentiated t…
-
CLINICAL_TRIALS research · 2025-11-14Clinical Trial Update: Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer [Phase 2]
A Phase 2 clinical trial is evaluating whether larotrectinib can enhance radioiodine uptake in differentiated thyroid cancer, including pedi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort
This trial update reports no prognostic or molecular disparity between synchronous and metachronous metastases in differentiated thyroid can…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Phase II Trial of Tunlametinib in NRAS-Mutant Advanced Thyroid Cancer [Phase 2]
Phase II trial of tunlametinib in NRAS-mutant advanced thyroid cancer is currently recruiting, evaluating differentiated, poorly differentia…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating the combination of cyclophosphamide and sirolimus for metastatic, radioiodine-refractory differentiated th…
-
CLINICAL_TRIALS trial_result · 2025-07-10Clinical Trial Update: Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating camrelizumab in combination with apatinib for radioactive iodine-refractory differentiated thyroid cancer; the stud…
-
CLINICAL_TRIALS research · 2025-07-09Clinical Trial Update: Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)
A planned clinical trial to assess outcomes of radioactive iodine therapy (Iodine-131) in patients with differentiated thyroid cancer at low…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: Targeted Alpha Therapy Using Astatine (At-211) Against Differentiated Thyroid Cancer [Phase 1]
Phase 1 trial evaluating astatine-211 targeted alpha therapy for differentiated thyroid cancer by Osaka University. The study status is COMP…
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Study of 177Lu-LNC1004 Injection in FAP-positive Radioiodine-refractory Differentiated Thyroid Cancer [EARLY_Phase 1]
Early-phase clinical trial evaluating 177Lu-LNC1004 injection for FAP-positive, radioiodine-refractory differentiated thyroid cancer, curren…
-
CLINICAL_TRIALS research · 2025-03-21Clinical Trial Update: The EMIRATES Study
The EMIRATES Study, sponsored by Royal Marsden NHS Foundation Trust, is a recruiting clinical trial investigating treatment for differentiat…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Impact of Thyroid Treatment on Ovarian Function and Pregnancy Outcomes in Women with Differentiated Thyroid Cancer [NA]
Clinical trial entry describing a planned study from Zhejiang Provincial People's Hospital to assess how thyroid treatment affects ovarian f…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: The Effect of a Psychosomatic Symptom Intervention Program on the Primary Treatment of Differentiated Thyroid Cancer [NA]
This clinical trial update describes a psychosomatic symptom intervention program being studied to assess its impact on the primary treatmen…
-
CLINICAL_TRIALS research · 2025-01-28Clinical Trial Update: Nomogram for Predicting Difficult Transoral and Submental Thyroidectomy
This clinical trial update indicates ongoing recruitment for a study to develop a nomogram predicting the difficulty of transoral and submen…
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Gender-based Impact on Safety and Efficacy of Lenvatinib in Patients With Differentiated Thyroid Cancer
A clinical trial update studying gender-based differences in the safety and efficacy of lenvatinib for differentiated thyroid cancer, with r…
-
CLINICAL_TRIALS research · 2024-11-01Clinical Trial Update: Sacituzumab govitEcan in THYroid Cancers [Phase 2]
A Phase 2 clinical trial evaluating Sacituzumab Govitecan in differentiated thyroid cancer and anaplastic thyroid cancer is currently recrui…
-
CLINICAL_TRIALS research · 2024-10-29Clinical Trial Update: Lateral Cervical Node Dissection in Differentiated Thyroid Cancer. [NA]
This clinical trial update shows that a study on lateral cervical node dissection for differentiated thyroid cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2024-10-03Clinical Trial Update: Primary Care Transfer for Thyroid Cancer Patients [NA]
An update on a trial examining primary care transfer for patients with differentiated thyroid cancer, showing the study is active but not re…
-
CLINICAL_TRIALS research · 2024-05-28Clinical Trial Update: Safety and Efficacy of Recombinant Human Thyroid Stimulating Hormone for Adjuvant Diagnosis in Patients With Locally Advanced/Metastatic Differentiated Thyroid Cancer [NA]
This clinical trial update indicates ongoing recruitment to evaluate the safety and efficacy of recombinant human thyroid-stimulating hormon…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients [Phase 2, Phase 3]
Clinical trial update on the IoN- study assessing whether ablative radio-iodine is necessary for low-risk differentiated thyroid cancer, spa…
-
CLINICAL_TRIALS research · 2024-05-08Clinical Trial Update: Recombinant Human Thyroid Stimulating Hormone for Radioiodine 131I Treatment [NA]
Ongoing clinical trial evaluating recombinant human thyroid-stimulating hormone (rhTSH) to facilitate Radioiodine 131I treatment in differen…
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: Comparison of the Efficacy and Safety of rhTSH as An Adjunctive Diagnostic Tool in Differentiated Thyroid Cancer Patients Who Had Been Thyroidectomized Vs. Patients Who After Thyroid Hormone Withdrawal [Phase 3]
A Phase 3 trial comparing rhTSH as an adjunctive diagnostic tool in differentiated thyroid cancer patients post-thyroidectomy versus after t…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Clinical Trial of Dose-tolerance, Pharmacokinetics and Iodine Uptake For rhTSH In Post-thyroidectomized Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating dose tolerance, pharmacokinetics, and iodine uptake for recombinant human thyroid-stimulating hormone (r…